Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Association of urodynamic findings in new onset multiple sclerosis with subsequent occurrence of urinary symptoms and acute episode of disease in females.
Promoting physical activity to control multiple sclerosis from childhood.
Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis.
Sodium channels in astroglia and microglia.
Patient and equipment profile for wheelchair seating clinic provision.
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
Primary varicella zoster infection associated with fingolimod treatment.
Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
Glutathione in multiple sclerosis: More than just an antioxidant?
CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review.
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15.
Re-expression of N-cadherin in remyelinating lesions of experimental inflammatory demyelination.
Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment-Past, Present, and Future Aspects.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Sodium channel Nav1.8: Emerging links to human disease.
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Remyelinate the Brain and Rescue Behavioral Deficits following Radiation.
Who receives rehabilitation in canadian long-term care facilities? A cross-sectional study.
Predictors of disability worsening in clinically isolated syndrome.
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Pages
« first
‹ previous
…
297
298
299
300
301
302
303
304
305
…
next ›
last »